In this issue:
EOC EV SPRI assay may improve early detection
Estimands for clinical effectiveness of RRES in women with high risk of ovarian cancer
Physician peers influence uptake of opportunistic salpingectomy
Substantial rate of missed opportunities to prevent ovarian cancer
Expert consensus supports HIPEC during cytoreductive surgery for HGSOC
Universal genetic testing is indicated for all patients with HGSOC, regardless of age
TROMP an effective and safe surgical approach for advanced ovarian cancer
UK study suggests that age should not be barrier to optimal treatment
Adult plus juvenile granulosa cell tumours are highly aggressive
CRS and CA-125 levels have prognostic utility after neoadjuvant chemotherapy
New blood test may replace HRD status for determination of PARP inhibitor response
Please login below to download this issue (PDF)